MediPharm Labs (CVE:LABS), through its subsidiary, is a pioneer in the cannabis industry and has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulations (ACMPR) without first receiving a cannabis cultivation licence. This expert focus on cannabis concentrates from our cGMP (current Good Manufacturing Practices) and ISO standard clean rooms and critical environments laboratory, allows MediPharm Labs to work with its established, Health Canada-approved cultivation partners to produce pharmaceutical-grade cannabis oil with a competitive advantage. MediPharm Labs is research-driven and focused on downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. MediPharm Labs, through its subsidiary, provides B2B contract processing of cannabis to Canadian authorized licensed producers and appropriate international growers, supplying integrity-assured cannabis oil to qualified companies for sale under their own brand. In addition, MediPharm Labs will supply raw materials, formulations, processing and packaging for the creation of ready-to-sell advanced derivative products. Through its subsidiary, MediPharm Labs Australia Pty. Ltd., MediPharm Labs has also completed its application process with the federal Office of Drug Control to extract and import medical cannabis products in Australia.
MediPharm Labs Corp.
CVE:LABS ISIN:CA58504D1006
News
MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to attach a copy of a news release announcing that MediPharm Labs Inc (CVE:LABS) has been added to the Horizons Marijuana Life Sciences Index ETF (TSE:HMMJ).
MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to attach a copy of a news release announcing that MediPharm Labs Inc (CVE:LABS) has entered into an 18-month strategic supply agreement with Canopy Growth Corporation (TSE:WEED) (NYSE:CGC).
MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to attach a copy of a news release by MediPharm Labs Inc (CVE:LABS) announcing that it has entered into a 3-year cannabis concentrate program agreement with Supreme Cannabis Company Inc (CVE:FIRE).
MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) is pleased to attach a copy of a news release by MediPharm Labs Inc (CVE:LABS) confirming that it has been issued a sales licence by Health Canada.
MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) is pleased to attach a copy of a news release by MediPharm Labs Inc (CVE:LABS) confirming achievement of the significant milestone of the purification and production of 150,000 grams of cannabis extract.
MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to attach a copy of the management presentation published by MediPharm Labs Inc (TSX-V: LABS).
11,123 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 31) (Last 30 Days: 125) (Since Published: 11123)